{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:59:57Z","timestamp":1790657997026,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["F31NS141369"],"award-info":[{"award-number":["F31NS141369"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS115488"],"award-info":[{"award-number":["R01NS115488"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS115488"],"award-info":[{"award-number":["R01NS115488"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-026-02370-3","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T10:26:14Z","timestamp":1783592774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CSF1R inhibition following antibody mediated demyelination has limited impact on remyelination"],"prefix":"10.1186","volume":"14","author":[{"given":"Lisa C.","family":"Golden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham C.","family":"Peet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca E.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Jahahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy B.","family":"Macklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"2370_CR1","doi-asserted-by":"publisher","first-page":"113574","DOI":"10.1016\/j.celrep.2023.113574","volume":"42","author":"CS Baaklini","year":"2023","unstructured":"Baaklini CS, Ho MFS, Lange T, Hammond BP, Panda SP, Zirngibl M et al (2023) Microglia promote remyelination independent of their role in clearing myelin debris. Cell Rep 42:113574. https:\/\/doi.org\/10.1016\/j.celrep.2023.113574","journal-title":"Cell Rep"},{"key":"2370_CR2","doi-asserted-by":"publisher","first-page":"eabb5077","DOI":"10.1126\/sciimmunol.abb5077","volume":"5","author":"R Berglund","year":"2020","unstructured":"Berglund R, Guerreiro-Cacais AO, Adzemovic MZ, Zeitelhofer M, Lund H, Ewing E et al (2020) Microglial autophagy\u2013associated phagocytosis is essential for recovery from neuroinflammation. Sci Immunol 5:eabb5077. https:\/\/doi.org\/10.1126\/sciimmunol.abb5077","journal-title":"Sci Immunol"},{"key":"2370_CR3","doi-asserted-by":"publisher","first-page":"e2871","DOI":"10.1038\/cddis.2017.256","volume":"8","author":"E Bonfanti","year":"2017","unstructured":"Bonfanti E, Gelosa P, Fumagalli M, Dimou L, Vigan\u00f2 F, Tremoli E et al (2017) The role of oligodendrocyte precursor cells expressing the GPR17 receptor in brain remodeling after stroke. Cell Death Dis 8:e2871\u2013e2871. https:\/\/doi.org\/10.1038\/cddis.2017.256","journal-title":"Cell Death Dis"},{"key":"2370_CR4","doi-asserted-by":"publisher","first-page":"e20220857","DOI":"10.1084\/jem.20220857","volume":"220","author":"JP Chadarevian","year":"2023","unstructured":"Chadarevian JP, Lombroso SI, Peet GC, Hasselmann J, Tu C, Marzan DE et al (2023) Engineering an inhibitor-resistant human CSF1R variant for microglia replacement. J Exp Med 220:e20220857. https:\/\/doi.org\/10.1084\/jem.20220857","journal-title":"J Exp Med"},{"key":"2370_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/glia.10038","volume":"37","author":"DM Chari","year":"2002","unstructured":"Chari DM, Blakemore WF (2002) Efficient recolonisation of progenitor-depleted areas of the CNS by adult oligodendrocyte progenitor cells. Glia 37:307\u2013313. https:\/\/doi.org\/10.1002\/glia.10038","journal-title":"Glia"},{"key":"2370_CR6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12974-019-1586-1","volume":"16","author":"T Chu","year":"2019","unstructured":"Chu T, Zhang YP, Tian Z, Ye C, Zhu M, Shields LBE et al (2019) Dynamic response of microglia\/macrophage polarization following demyelination in mice. J Neuroinflammation 16:188. https:\/\/doi.org\/10.1186\/s12974-019-1586-1","journal-title":"J Neuroinflammation"},{"key":"2370_CR7","doi-asserted-by":"publisher","first-page":"102787","DOI":"10.1016\/j.msard.2021.102787","volume":"49","author":"KR Cotchett","year":"2021","unstructured":"Cotchett KR, Dittel BN, Obeidat AZ (2021) Comparison of the Efficacy and Safety of Anti-CD20 B Cells Depleting Drugs in Multiple Sclerosis. Mult Scler Relat Disord 49:102787. https:\/\/doi.org\/10.1016\/j.msard.2021.102787","journal-title":"Mult Scler Relat Disord"},{"key":"2370_CR8","doi-asserted-by":"publisher","unstructured":"Craig GA, Ryan L, Thapar J, McNamara NB, Hoffmann A, Page D et al (2024) Reflective imaging of myelin integrity in the human and mouse central nervous systems. Front Cell Neurosci 18. https:\/\/doi.org\/10.3389\/fncel.2024.1408182","DOI":"10.3389\/fncel.2024.1408182"},{"key":"2370_CR9","doi-asserted-by":"publisher","first-page":"eaam7816","DOI":"10.1126\/scitranslmed.aam7816","volume":"9","author":"MK Fard","year":"2017","unstructured":"Fard MK, van der Meer F, S\u00e1nchez P, Cantuti-Castelvetri L, Mandad S, J\u00e4kel S et al (2017) BCAS1 expression defines a population of early myelinating oligodendrocytes in multiple sclerosis lesions. Sci Transl Med 9:eaam7816. https:\/\/doi.org\/10.1126\/scitranslmed.aam7816","journal-title":"Sci Transl Med"},{"key":"2370_CR10","doi-asserted-by":"publisher","first-page":"e20210542","DOI":"10.1084\/jem.20210542","volume":"218","author":"M Gratuze","year":"2021","unstructured":"Gratuze M, Chen Y, Parhizkar S, Jain N, Strickland MR, Serrano JR et al (2021) Activated microglia mitigate A\u03b2-associated tau seeding and spreading. J Exp Med 218:e20210542. https:\/\/doi.org\/10.1084\/jem.20210542","journal-title":"J Exp Med"},{"key":"2370_CR11","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/glia.24664","volume":"73","author":"D Guenoun","year":"2025","unstructured":"Guenoun D, Blaise N, Sellam A, Roupret-Serzec J, Jacquens A, Steenwinckel JV et al (2025) Microglial Depletion, a New Tool in Neuroinflammatory Disorders: Comparison of Pharmacological Inhibitors of the CSF-1R. Glia 73:686\u2013700. https:\/\/doi.org\/10.1002\/glia.24664","journal-title":"Glia"},{"key":"2370_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/glia.24249","volume":"71","author":"F Guo","year":"2023","unstructured":"Guo F, Wang Y (2023) TCF7l2, a nuclear marker that labels premyelinating oligodendrocytes and promotes oligodendroglial lineage progression. Glia 71:143\u2013154. https:\/\/doi.org\/10.1002\/glia.24249","journal-title":"Glia"},{"key":"2370_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40478-015-0192-4","volume":"3","author":"M Kocur","year":"2015","unstructured":"Kocur M, Schneider R, Pulm A-K, Bauer J, Kropp S, Gliem M et al (2015) IFN\u03b2 secreted by microglia mediates clearance of myelin debris in CNS autoimmunity. Acta Neuropathol Commun 3:20. https:\/\/doi.org\/10.1186\/s40478-015-0192-4","journal-title":"Acta Neuropathol Commun"},{"key":"2370_CR14","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/glia.1085","volume":"35","author":"MR Kotter","year":"2001","unstructured":"Kotter MR, Setzu A, Sim FJ, Van Rooijen N, Franklin RJ (2001) Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 35:204\u2013212. https:\/\/doi.org\/10.1002\/glia.1085","journal-title":"Glia"},{"key":"2370_CR15","doi-asserted-by":"publisher","first-page":"21512","DOI":"10.1073\/pnas.2011249117","volume":"117","author":"S Kuerten","year":"2020","unstructured":"Kuerten S, Lanz TV, Lingampalli N, Lahey LJ, Kleinschnitz C, M\u00e4urer M et al (2020) Autoantibodies against central nervous system antigens in a subset of B cell\u2013dominant multiple sclerosis patients. Proc Natl Acad Sci 117:21512\u201321518. https:\/\/doi.org\/10.1073\/pnas.2011249117","journal-title":"Proc Natl Acad Sci"},{"key":"2370_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","volume":"603","author":"TV Lanz","year":"2022","unstructured":"Lanz TV, Brewer RC, Ho PP, Moon J-S, Jude KM, Fernandez D et al (2022) Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature 603:321\u2013327. https:\/\/doi.org\/10.1038\/s41586-022-04432-7","journal-title":"Nature"},{"key":"2370_CR17","doi-asserted-by":"publisher","first-page":"9394","DOI":"10.1038\/s41598-023-36532-3","volume":"13","author":"Y Li","year":"2023","unstructured":"Li Y, Noto D, Hoshino Y, Mizuno M, Yoshikawa S, Miyake S (2023) Immunoglobulin directly enhances differentiation of oligodendrocyte-precursor cells and remyelination. Sci Rep 13:9394. https:\/\/doi.org\/10.1038\/s41598-023-36532-3","journal-title":"Sci Rep"},{"key":"2370_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40478-017-0428-6","volume":"5","author":"Y Liu","year":"2017","unstructured":"Liu Y, Given KS, Harlow DE, Matschulat AM, Macklin WB, Bennett JL, Owens GP (2017) Myelin-specific multiple sclerosis antibodies cause complement-dependent oligodendrocyte loss and demyelination. Acta Neuropathol Commun 5:25. https:\/\/doi.org\/10.1186\/s40478-017-0428-6","journal-title":"Acta Neuropathol Commun"},{"key":"2370_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.expneurol.2019.04.011","volume":"318","author":"Y Liu","year":"2019","unstructured":"Liu Y, Given KS, Dickson EL, Owens GP, Macklin WB, Bennett JL (2019) Concentration-dependent effects of CSF1R inhibitors on oligodendrocyte progenitor cells ex vivo and in vivo. Exp Neurol 318:32\u201341. https:\/\/doi.org\/10.1016\/j.expneurol.2019.04.011","journal-title":"Exp Neurol"},{"key":"2370_CR20","doi-asserted-by":"publisher","first-page":"e70120","DOI":"10.1002\/glia.70120","volume":"74","author":"HK Loo","year":"2026","unstructured":"Loo HK, Gallegos J, Mialki C, Perrin GE, Malloy T, Orthmann-Murphy JL (2026) Depletion of Microglia Increases Cortical Oligodendrocyte Density During Remyelination. Glia 74:e70120. https:\/\/doi.org\/10.1002\/glia.70120","journal-title":"Glia"},{"key":"2370_CR21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jneumeth.2018.05.024","volume":"307","author":"Q Luo","year":"2018","unstructured":"Luo Q, Ding L, Zhang N, Jiang Z, Gao C, Xue L et al (2018) A stable and easily reproducible model of focal white matter demyelination. J Neurosci Methods 307:230\u2013239. https:\/\/doi.org\/10.1016\/j.jneumeth.2018.05.024","journal-title":"J Neurosci Methods"},{"key":"2370_CR22","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/glia.23980","volume":"69","author":"DE Marzan","year":"2021","unstructured":"Marzan DE, Br\u00fcgger-Verdon V, West BL, Liddelow S, Samanta J, Salzer JL (2021) Activated microglia drive demyelination via CSF1R signaling. Glia 69:1583\u20131604. https:\/\/doi.org\/10.1002\/glia.23980","journal-title":"Glia"},{"key":"2370_CR23","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0002-9440(10)65617-9","volume":"153","author":"A Matsuo","year":"1998","unstructured":"Matsuo A, Akiguchi I, Lee GC, McGeer EG, McGeer PL, Kimura J (1998) Myelin Degeneration in Multiple System Atrophy Detected by Unique Antibodies. Am J Pathol 153:735\u2013744. https:\/\/doi.org\/10.1016\/S0002-9440(10)65617-9","journal-title":"Am J Pathol"},{"key":"2370_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1750-3639.2001.tb00385.x","volume":"11","author":"GK Matsushima","year":"2001","unstructured":"Matsushima GK, Morell P (2001) The Neurotoxicant, Cuprizone, as a Model to Study Demyelination and Remyelination in the Central Nervous System. Brain Pathol 11:107\u2013116. https:\/\/doi.org\/10.1111\/j.1750-3639.2001.tb00385.x","journal-title":"Brain Pathol"},{"key":"2370_CR25","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/nn.3469","volume":"16","author":"VE Miron","year":"2013","unstructured":"Miron VE, Boyd A, Zhao J-W, Yuen TJ, Ruckh JM, Shadrach JL et al (2013) M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat Neurosci 16:1211\u20131218. https:\/\/doi.org\/10.1038\/nn.3469","journal-title":"Nat Neurosci"},{"key":"2370_CR26","doi-asserted-by":"publisher","first-page":"eadu2896","DOI":"10.1126\/science.adu2896","volume":"391","author":"YA Mironova","year":"2026","unstructured":"Mironova YA, Dang B, Heo D, Xu YKT, Hsu AY-H, von Eugenin J et al (2026) Myelin is repaired by constitutive differentiation of oligodendrocyte progenitors. Science 391:eadu2896. https:\/\/doi.org\/10.1126\/science.adu2896","journal-title":"Science"},{"key":"2370_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.expneurol.2018.05.021","volume":"307","author":"JC Nissen","year":"2018","unstructured":"Nissen JC, Thompson KK, West BL, Tsirka SE (2018) Csf1R inhibition attenuates experimental autoimmune encephalomyelitis and promotes recovery. Exp Neurol 307:24\u201336. https:\/\/doi.org\/10.1016\/j.expneurol.2018.05.021","journal-title":"Exp Neurol"},{"key":"2370_CR28","doi-asserted-by":"publisher","first-page":"e200212","DOI":"10.1212\/NXI.0000000000200212","volume":"11","author":"J Oechtering","year":"2024","unstructured":"Oechtering J, Stein K, Schaedelin SA, Maceski AM, Orleth A, Meier S et al (2024) Complement Activation Is Associated With Disease Severity in Multiple Sclerosis. Neurol Neuroimmunol Neuroinflammation 11:e200212. https:\/\/doi.org\/10.1212\/NXI.0000000000200212","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"2370_CR29","doi-asserted-by":"publisher","first-page":"e200361","DOI":"10.1212\/NXI.0000000000200361","volume":"12","author":"J Oechtering","year":"2025","unstructured":"Oechtering J, Schaedelin SA, Stein K, Maleska Maceski A, Melie-Garcia L, Benkert P et al (2025) Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis. Neurol Neuroimmunol Neuroinflammation 12:e200361. https:\/\/doi.org\/10.1212\/NXI.0000000000200361","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"2370_CR30","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.4049\/jimmunol.1200356","volume":"189","author":"MB Overdijk","year":"2012","unstructured":"Overdijk MB, Verploegen S, Ortiz Buijsse A, Vink T, Leusen JHW, Bleeker WK, Parren PWHI (2012) Crosstalk between Human IgG Isotypes and Murine Effector Cells. J Immunol 189:3430\u20133438. https:\/\/doi.org\/10.4049\/jimmunol.1200356","journal-title":"J Immunol"},{"key":"2370_CR31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/ana.21641","volume":"65","author":"GP Owens","year":"2009","unstructured":"Owens GP, Bennett JL, Lassmann H, O\u2019Connor KC, Ritchie AM, Shearer A et al (2009) Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid. Ann Neurol 65:639\u2013649. https:\/\/doi.org\/10.1002\/ana.21641","journal-title":"Ann Neurol"},{"key":"2370_CR32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI162731","author":"GP Owens","year":"2023","unstructured":"Owens GP, Fellin TJ, Matschulat A, Salas V, Schaller KL, Given KS et al (2023) Pathogenic myelin specific antibodies in multiple sclerosis target conformational proteolipid protein 1 anchored membrane domains. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI162731","journal-title":"J Clin Invest"},{"key":"2370_CR33","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1523\/JNEUROSCI.18-07-02498.1998","volume":"18","author":"KD Pavelko","year":"1998","unstructured":"Pavelko KD, van Engelen BGM, Rodriguez M (1998) Acceleration in the Rate of CNS Remyelination in Lysolecithin-Induced Demyelination. J Neurosci 18:2498\u20132505. https:\/\/doi.org\/10.1523\/JNEUROSCI.18-07-02498.1998","journal-title":"J Neurosci"},{"key":"2370_CR34","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1093\/brain\/awab231","volume":"144","author":"K Pellerin","year":"2021","unstructured":"Pellerin K, Rubino SJ, Burns JC, Smith BA, McCarl C-A, Zhu J et al (2021) MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response. Brain J Neurol 144:2361\u20132374. https:\/\/doi.org\/10.1093\/brain\/awab231","journal-title":"Brain J Neurol"},{"key":"2370_CR35","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12974-017-0984-5","volume":"14","author":"P Peschl","year":"2017","unstructured":"Peschl P, Schanda K, Zeka B, Given K, B\u00f6hm D, Ruprecht K et al (2017) Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination. J Neuroinflammation 14:208. https:\/\/doi.org\/10.1186\/s12974-017-0984-5","journal-title":"J Neuroinflammation"},{"key":"2370_CR36","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1212\/01.CON.0000433291.23091.65","volume":"19","author":"I Popescu BFGh, Pirko","year":"2013","unstructured":"Popescu BFGh, Pirko I, Lucchinetti CF (2013) Pathology of Multiple Sclerosis: Where Do We Stand? Contin Lifelong Learn Neurol 19:901\u2013921. https:\/\/doi.org\/10.1212\/01.CON.0000433291.23091.65","journal-title":"Contin Lifelong Learn Neurol"},{"key":"2370_CR37","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/jnen\/nlab083","volume":"80","author":"JW Prineas","year":"2021","unstructured":"Prineas JW, Parratt JDE (2021) Multiple Sclerosis: Microglia, Monocytes, and Macrophage-Mediated Demyelination. J Neuropathol Exp Neurol 80:975\u2013996. https:\/\/doi.org\/10.1093\/jnen\/nlab083","journal-title":"J Neuropathol Exp Neurol"},{"key":"2370_CR38","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00401-013-1172-z","volume":"126","author":"J Ratelade","year":"2013","unstructured":"Ratelade J, Asavapanumas N, Ritchie AM, Wemlinger S, Bennett JL, Verkman AS (2013) Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica. Acta Neuropathol (Berl) 126:699\u2013709. https:\/\/doi.org\/10.1007\/s00401-013-1172-z","journal-title":"Acta Neuropathol (Berl)"},{"key":"2370_CR39","doi-asserted-by":"publisher","first-page":"24464","DOI":"10.1073\/pnas.2007814117","volume":"117","author":"A Sariol","year":"2020","unstructured":"Sariol A, Mackin S, Allred M-G, Ma C, Zhou Y, Zhang Q et al (2020) Microglia depletion exacerbates demyelination and impairs remyelination in a neurotropic coronavirus infection. Proc Natl Acad Sci 117:24464\u201324474. https:\/\/doi.org\/10.1073\/pnas.2007814117","journal-title":"Proc Natl Acad Sci"},{"key":"2370_CR40","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/brain\/aww016","volume":"139","author":"EE Spangenberg","year":"2016","unstructured":"Spangenberg EE, Lee RJ, Najafi AR, Rice RA, Elmore MRP, Blurton-Jones M et al (2016) Eliminating microglia in Alzheimer\u2019s mice prevents neuronal loss without modulating amyloid-\u03b2 pathology. Brain J Neurol 139:1265\u20131281. https:\/\/doi.org\/10.1093\/brain\/aww016","journal-title":"Brain J Neurol"},{"key":"2370_CR41","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/ana.410430409","volume":"43","author":"MK Storch","year":"1998","unstructured":"Storch MK, Piddlesden S, Haltia M, Iivanainen M, Morgan P, Lassmann H (1998) Multiple sclerosis: In situ evidence for antibody- and complement-mediated demyelination. Ann Neurol 43:465\u2013471. https:\/\/doi.org\/10.1002\/ana.410430409","journal-title":"Ann Neurol"},{"key":"2370_CR42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1471-4159.1991.tb02104.x","volume":"57","author":"FA Tansey","year":"1991","unstructured":"Tansey FA, Cammer W (1991) A pi form of glutathione-S-transferase is a myelin- and oligodendrocyte-associated enzyme in mouse brain. J Neurochem 57:95\u2013102. https:\/\/doi.org\/10.1111\/j.1471-4159.1991.tb02104.x","journal-title":"J Neurochem"},{"key":"2370_CR43","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40659-024-00529-7","volume":"57","author":"S Vejar","year":"2024","unstructured":"Vejar S, Pizarro IS, Pulgar-Sep\u00falveda R, Vicencio SC, Polit A, Amador CA et al (2024) A preclinical mice model of multiple sclerosis based on the toxin-induced double-site demyelination of callosal and cerebellar fibers. Biol Res 57:48. https:\/\/doi.org\/10.1186\/s40659-024-00529-7","journal-title":"Biol Res"},{"key":"2370_CR44","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.nbd.2011.09.008","volume":"45","author":"EV Vo\u00df","year":"2012","unstructured":"Vo\u00df EV, \u0160kuljec J, Gudi V, Skripuletz T, Pul R, Trebst C, Stangel M (2012) Characterisation of microglia during de- and remyelination: Can they create a repair promoting environment? Neurobiol Dis 45:519\u2013528. https:\/\/doi.org\/10.1016\/j.nbd.2011.09.008","journal-title":"Neurobiol Dis"},{"key":"2370_CR45","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA et al (2020) Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler J 26:1816\u20131821. https:\/\/doi.org\/10.1177\/1352458520970841","journal-title":"Mult Scler J"},{"key":"2370_CR46","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/brain\/123.1.105","volume":"123","author":"G Wolswijk","year":"2000","unstructured":"Wolswijk G (2000) Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis. Brain 123:105\u2013115. https:\/\/doi.org\/10.1093\/brain\/123.1.105","journal-title":"Brain"},{"key":"2370_CR47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jneuroim.2005.11.010","volume":"172","author":"X Yu","year":"2006","unstructured":"Yu X, Gilden DH, Ritchie AM, Burgoon MP, Keays KM, Owens GP (2006) Specificity of recombinant antibodies generated from multiple sclerosis cerebrospinal fluid probed with a random peptide library. J Neuroimmunol 172:121\u2013131. https:\/\/doi.org\/10.1016\/j.jneuroim.2005.11.010","journal-title":"J Neuroimmunol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-026-02370-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02370-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02370-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:44:44Z","timestamp":1790657084000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-026-02370-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2370"],"URL":"https:\/\/doi.org\/10.1186\/s40478-026-02370-3","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"25 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were performed with approval from the Institutional Animal Care and Use Committee (IACUC) at the University of Colorado, Anschutz Medical Campus. No new recombinant human antibodies were derived for this work; all rAbs were generated in previous studies [\n                      \n                      ].","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LCG: Nothing to disclose. GCP: Nothing to disclose. NJJ: Nothing to disclose. RER: Nothing to disclose. GPO: Nothing to disclose. JLB: Reports personal fees from Alexion AstraZeneca Rare Disease, Antigenomycs, BeiGene, Chugai, Clene Nanomedicine, Genentech, Genzyme, Reistone Bio, Roche, Imcyse, Mitsubishi-Tanabe, and TG; speaker fees from Alexion; grants from Alexion. WBM: Nothing to disclose.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"197"}}